Cleveland Clinic Abu Dhabi and MBZUAI have signed an MoU to collaborate on research and education initiatives. The partnership aims to create opportunities such as joint research projects and mentorship programs for students. Both institutions will leverage their expertise to explore AI applications in healthcare, focusing on areas like diagnostics and digital twins. Why it matters: The collaboration will strengthen Abu Dhabi's position as a hub for AI-enabled healthcare innovation and talent development.
MBZUAI and Cleveland Clinic Abu Dhabi jointly showcased AI applications to address UAE healthcare challenges, focusing on diabetes, heart disease, and vision loss. The event highlighted AI-powered robots for surgical tool guidance, autonomous ultrasound systems, and AI-based eye diagnostics for early disease detection. Researchers presented advances in AI-powered intrabody navigation, robotic ultrasound imaging, and AI-based oculomics. Why it matters: These AI innovations have the potential to transform healthcare delivery in the UAE, improving surgical outcomes, democratizing access to diagnostic imaging, and enabling earlier disease detection.
The Abu Dhabi Department of Health (DoH) has partnered with MBZUAI and Core42 to launch the Global AI Healthcare Academy. The academy will provide AI training to healthcare workers in Abu Dhabi, aiming to improve diagnostics, operational efficiency, and patient care. The initiative includes mass training sessions for up to 100 attendees and customized courses in areas like AI for radiology and cardiology. Why it matters: This partnership signals a strategic push to integrate AI into Abu Dhabi's healthcare system, potentially establishing the emirate as a leader in technology-driven healthcare.
SEHA and MBZUAI have signed an MoU to integrate AI into medical care and enhance clinical expertise. They will collaborate on AI-driven solutions for quantifying COVID-19 infection severity and study its long-term impact on UAE residents. The partnership will also focus on diagnosis and treatment methods for acute kidney injury, coronary artery disease, fetal health, and AI-driven point of care ultrasound. Why it matters: This collaboration between a major healthcare provider and an AI university in the UAE could lead to advancements in AI-driven healthcare solutions and improve patient outcomes.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
MBZUAI researchers led by Dr. Mohammad Yaqub are developing AI algorithms for real-time medical diagnoses, including tools for multiple sclerosis and congenital heart disease. The team developed ScanNav, an AI fetal anomaly assessment system licensed by GE Healthcare for Voluson SWIFT ultrasound machines. ScanNav assists doctors during anomaly scans after 20 weeks of gestation to check for conditions like heart issues and spina bifida. Why it matters: This research has the potential to significantly improve the speed and accuracy of medical diagnoses in the UAE and beyond, addressing critical gaps in healthcare.
The inaugural Abu Dhabi AI-Robotics Conference was held at MBZUAI, focusing on AI-powered robotics to transform healthcare. Experts explored applications in microsurgery, biorobotics, and personalized treatment, with keynotes from H.E. Abdulla Abdulalee AlHumaidan, Timothy Baldwin, and Sami Haddadin. Dr. Hassa Al Mazrouei highlighted the potential for personalized care and automation driven by AI. Why it matters: The conference underscores the UAE's commitment to advancing AI and robotics in healthcare, potentially positioning the region as a leader in innovative medical technologies.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.